News Sign up to receive news alerts. Your Email* YOUR EMAIL Havn Life Sciences announces Investor Relations Marketing Campaigns December 4, 2020 Havn Life Sciences partners with veterans mental health non-profit, Westwood Institute December 3, 2020 Havn Life attracts international drug science and policy expert, joins UK policy reform group December 1, 2020 Havn Life Sciences announces $5.46 million warrant exercise November 24, 2020 Havn Life announces Voluntary Escrow of 6,300,000 Shares November 18, 2020 Havn Life announces launch of a range of Natural Health Products November 11, 2020 Havn Life Sciences to support the first modern psilocybin depression study in Germany with MIND Foundation October 30, 2020 Havn Life Sciences earns Health Canada approval for natural health product formulations October 26, 2020 Havn Life Sciences signs agreement to supply psychedelic compounds for use in research and development to Revive Therapeutics October 20, 2020 Havn Life Sciences announces appointment of Dennis Staudt to the Board of Directors & Senior Management Reorganization October 19, 2020 Havn Life applies for licence to produce and sell psilocybin October 13, 2020 Havn Life Sciences announces appointments of Vic Neufeld as Chairman and Rick Brar as Vice Chairman of the Board of Directors, respectively, and the acceleration of Warrants October 5, 2020
